Gene expression in brain during cuprizone-induced demyelination and remyelination

Molecular and Cellular Neurosciences

Volumn 12, Issue 4-5, 1998, Pages 220-227

  Morell, P ^a,b   Barrett, C V ^a   Mason, J L ^b   Toews, A D ^a   Hostettler, J D ^a   Knapp, G W ^a   Matsushima, G K ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; DEMYELINATION; GENE EXPRESSION REGULATION; MACROPHAGE; MICROGLIA; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REMYELINIZATION; TRANSCRIPTION REGULATION;

EID: 0031761662     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1998.0715     Document Type: Article

References (38)

1. Bakker D. A., Ludwin S. K. Blood brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating disease. J. Neurol. Sci. 89:1987;125-137.
2. Barry C., Pearson C., Barbarese E. Morphological organization of oligodendrocyte processes during development in culture andin vivo. Dev. Neurosci. 18:1996;233-242.
3. Blakemore W. F. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J. Neurocytol. 1:1972;413-426.
4. Blakemore W. F. Demyelination of the superior cerebellar peduncle in the mouse induced by Cuprizone. J. Neurol. Sci. 20:1973a;63-72.
5. Blakemore W. F. Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding Cuprizone. J. Neurol. Sci. 20:1973b;73-83.
6. Bodhireddy S. R., Lyman W. D., Rashbaum W. K., Weidenheim K. M. Immunohistochemical detection of myelin basic protein is a sensitive marker of myelination in second trimester human fetal spinal cord. J. Neuropathol. Exp. Neurol. 53:1994;44-149.
7. Boya J., Calvo J. L., Carbonell A. L., Borregon A. A lectin histochemistry study on the development of rat microglial cells. J. Anat. 175:1991;229-236.
8. Carey E. M., Freeman N. M. Biochemical changes in Cuprizone-induced spongiform encephalopathy. I. Changes in the activities of 2′,3′-cyclic nucleotide 3′-phosphohydrolase, oligodendroglial ceramide galactosyl transferase, and the hydrolysis of the alkenyl group of alkenyl, acyl-glycerophospholipids by plasmalogenase in different regions of the brain. Neurochem. Res. 8:1983;1029-1044.
9. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
10. Diemel L. T., Copelman C. A., Cuzner M. L. Macrophages in CNS remyelination: Friend or foe. Neurochem. Res. 23:1998;341-347.
11. Fujita N., Ishiguro H., Sato S., Kurihara T., Kuwano R., Takahashi Y., Miyatake T. Induction of myelin-associated glycoprotein mRNA in experimental remyelination. Brain Res. 513:1990;152-155.
12. Hadjiolov A. A., Georgiev O. I., Nosikov V. V., Yavachev L. P. Primary and secondary structure of rat 28 S ribosomal RNA. Nucleic Acids Res. 12:1984;3677-3693.
13. Hall S. M. The effect of injections of lysophosphatidly choline into white matter of the adult mouse spinal cord. J. Cell. Sci. 10:1972;535-546.
14. Hamilton S. P., Rome L. J. Stimulation ofin vitro. Glia. 11:1994;326-335.
15. Hiremath M. M., Saito Y., Knapp G. W., Ting J. P.-Y., Suzuki K., Matsushima G. K. Microglial/macrophage accumulation during Cuprizone-induced demyelination in C57BL/6mice. J. Neuroimmunol. 1998.
16. Jansen R., Ledley F. D. Production of high specific activity DNA probes using the polymerase chain reaction. Gene Anal. Techn. 6:1989;79-83.
17. Keirstead H. S., Blakemore W. F. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J. Neuropathol. Exp. Neurol. 56:1997;1191-1201.
18. Komoly S., Hudson L. D., Webster H. DeF., Bondy C. A. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc. Natl. Acad. Sci. USA. 89:1992;1894-1898.
19. Komoly S., Jeyasingham M. D., Pratt O. E., Lantos P. L. Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination. J. Neurol. Sci. 79:1987;141-148.
20. Kondo A., Nakano T., Suzuki K. Blood brain barrier permeability in twitcher and Cuprizone-intoxicated mice. Dev. Brain. Res. 425:1987;186-190.
21. Lai C., Brow M. A., Nave K.-A., Noronha A. B., Quarles R. H., Bloom F. E., Milner R. J., Sutcliffe J. G. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal development, are produced by alternative splicing. Proc. Natl. Acad. Sci. USA. 84:1987;4337-4341.
22. Ludwin S. K. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39:1978;597-612.
23. Ludwin S. K. An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am. J. Pathol. 95:1979;683-696.
24. Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning: A Laboratory Manual. 1982;Cold Spring Harbor Laboratory, Cold Spring Harbor. p. 122-123.
25. Mannoji H., Yeger H., Beaker L. E. A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia and application of routine histopathology. Acta Neuropathol. 71:1986;341-343.
26. Mason J. L., Barrett C., Morell P., Matsushima G. K. A possible role for microglia/macrophage-derived cytokines in initiating the remyelination process. Int. J. Dev. Neurosci. (Abstr). 1998.
27. Miller D. J., Asakura K., Rodriguez M. Central nervous system remyelination. Clinical application of basic neuroscience principles. Brain Pathol. 6:1996;331-344.
28. Quarles R. H., Morell P., McFarlin D. E. Diseases involving myelin. Basic Neurochemistry. 1994;Raven Press, New York. p. 771-792.
29. Roach A., Boylan K., Horvath S., Prusiner S. B., Hood L. E. Characterization of cloned cDNA representing rat myelin basic protein: Absence of expression in brain of shiverer mutant mice. Cell. 31:1983;799-806.
30. Scholtz C. L. Quantitative histochemistry of myelin using Luxol Fast Blue MBS. Histochem. J. 9:1997;759-765.
31. 2+. J. Biol. Chem. 272:1997;22654-22661.
32. Stahl N., Jurevics H., Morell P., Suzuki K., Popko B. Isolation, characterization, and expression of cDNA clones that encode UDP-galactose:ceramide galactosyltransferase. J. Neurosci. Res. 38:1994;234-242.
33. Suzuki K., Kikkawa Y. Status spongiosus of CNS and hepatic changes induced by cuprizone (bis. Am. J. Pathol. 54:1969;307-325.
34. Tanaka S., Mito T., Takashima S. Progress of myelination in the human fetal spinal nerve roots, spinal cord and brainstem with myelin basic protein immunohistochemistry. Early Hum. Dev. 41:1995;49-59.
35. Tansey F. A., Zhang H., Cammer W. Expression of carbonic anhydrase II mRNA and protein in oligodendrocytes during toxic demyelination in the young adult mouse. Neurochem. Res. 21:1996;411-416.
36. Toews A. D., Lee S. Y., Popko B., Morell P. Tellurium-induced neuropathy: A model for reversible reductions in myelin gene expression. J. Neurosci. Res. 26:1990;501-507.
37. Venezie R. D., Toews A. D., Morell P. Macrophage recruitment in different models of nerve injury: Lysozyme as a marker for active phagocytosis. J. Neurosci. Res. 40:1995;99-107.
38. Yajima K., Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab. Invest. 41:1979;385-392.